Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers... Show more
Cardinal Health, a leading pharmaceutical and medical products distributor, pays a quarterly cash dividend of approximately $0.5158 per share, which translates to an annualized dividend of about $2.06 per share. Based on recent share prices, that produces a dividend yield of roughly 0.9% to 1.0%, making Cardinal Health a modest-yield dividend stock rather than a high-yield income play.
The company has maintained a consistent quarterly payment schedule for more than three decades, with ex-dividend dates generally occurring near the beginning of each quarter and distributions paid around the 15th of the month. While the dividend grows slowly, its reliability and conservative structure are central to Cardinal Health's income profile. Investors should view CAH primarily as a dividend safety and modest-growth name, with total returns depending more on share-price appreciation than on dividend income.
Cardinal Health has a long history of returning cash to shareholders. The quarterly payout has moved up in small, predictable increments in recent years, rising from about $0.4957 per share in 2022 to $0.5056 in 2025 and approximately $0.5158 by 2026. This reflects an annual dividend growth rate of roughly 1% in recent periods and about 2.4% per year over the past decade, according to dividend history data.
Importantly, the company has avoided cuts through various market cycles, maintaining steady payments and gradually increasing them over time. This pattern signals a deliberate, conservative capital-return policy rather than aggressive payout expansion. For dividend investors, CAH's track record points to dependability, though the pace of dividend growth is modest compared with faster-growing dividend payers in other sectors.
Cardinal Health's dividend appears highly sustainable. The payout ratio stands near 28% to 32% of earnings, meaning the company retains roughly two-thirds of its profits to reinvest in the business, fund share repurchases, and reduce debt. This low payout ratio provides a wide cushion that can absorb earnings fluctuations without threatening the dividend.
Beyond earnings, Cardinal Health generates substantial free cash flow from its pharmaceutical distribution operations, supporting both its dividend and share buybacks. The company's scale in the healthcare supply chain contributes to relatively stable cash generation. This financial foundation suggests the dividend is well-covered and that CAH has the flexibility to maintain or gradually increase its payout even if operating conditions soften.
Within the healthcare distribution and pharmaceutical supply space, Cardinal Health's dividend profile is broadly in line with its closest peers. Fellow distributors such as MCK (McKesson) and COR (Cencora) also pay relatively modest dividends, with yields generally below or near 1% and similarly conservative payout ratios. This reflects an industry-wide preference for reinvestment and share buybacks over high cash distributions.
By contrast, diversified healthcare names such as CVS (CVS Health) offer notably higher yields, though those higher yields often come with elevated payout ratios and greater financial leverage. In this context, Cardinal Health's sub-1% yield is typical for a distribution-focused business and sits at the lower end of the broader healthcare sector's yield range.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and exchange-traded funds (ETFs) using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify dividend stocks, income-focused investments, trending stocks, and breakout candidates more efficiently than manual screening. For investors seeking reliable dividend payers or new market opportunities, exploring the AI Screener can be a practical way to streamline research and uncover ideas aligned with your objectives.
Cardinal Health is likely to appeal most to conservative, long-term dividend investors who prioritize payment reliability over high current yield. Its low payout ratio, stable cash generation, and decades-long history of consistent distributions make it a defensive holding within a diversified income portfolio. Investors who value dividend safety and modest, incremental growth may find CAH's profile attractive.
However, income-focused investors seeking substantial yield will likely find the sub-1% payout underwhelming relative to higher-yielding alternatives in healthcare and other sectors. Likewise, dividend growth investors may view the roughly 1% annual increase rate as too slow to meaningfully offset inflation. Ultimately, CAH is best understood as a total-return story where steady dividends and share repurchases complement the company's operational strength, rather than as a primary source of income. Each investor should weigh these characteristics against their own financial goals and risk tolerance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a maker of pharmaceuticals, medical, surgical and laboratory supplies as well as develops drug delivery systems
Industry MedicalDistributors